227 related articles for article (PubMed ID: 21883147)
1. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.
Bashashati M; Storr MA; Nikas SP; Wood JT; Godlewski G; Liu J; Ho W; Keenan CM; Zhang H; Alapafuja SO; Cravatt BF; Lutz B; Mackie K; Kunos G; Patel KD; Makriyannis A; Davison JS; Sharkey KA
Br J Pharmacol; 2012 Mar; 165(5):1556-71. PubMed ID: 21883147
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.
Fichna J; Sałaga M; Stuart J; Saur D; Sobczak M; Zatorski H; Timmermans JP; Bradshaw HB; Ahn K; Storr MA
Neurogastroenterol Motil; 2014 Apr; 26(4):470-81. PubMed ID: 24460851
[TBL] [Abstract][Full Text] [Related]
3. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
[TBL] [Abstract][Full Text] [Related]
4. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
5. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.
de Filippis D; Iuvone T; d'amico A; Esposito G; Steardo L; Herman AG; Pelckmans PA; de Winter BY; de Man JG
Neurogastroenterol Motil; 2008 Aug; 20(8):919-27. PubMed ID: 18373655
[TBL] [Abstract][Full Text] [Related]
6. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.
Godlewski G; Alapafuja SO; Bátkai S; Nikas SP; Cinar R; Offertáler L; Osei-Hyiaman D; Liu J; Mukhopadhyay B; Harvey-White J; Tam J; Pacak K; Blankman JL; Cravatt BF; Makriyannis A; Kunos G
Chem Biol; 2010 Nov; 17(11):1256-66. PubMed ID: 21095576
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.
Storr MA; Bashashati M; Hirota C; Vemuri VK; Keenan CM; Duncan M; Lutz B; Mackie K; Makriyannis A; Macnaughton WK; Sharkey KA
Neurogastroenterol Motil; 2010 Jul; 22(7):787-96, e223. PubMed ID: 20180825
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.
Izzo AA; Capasso R; Aviello G; Borrelli F; Romano B; Piscitelli F; Gallo L; Capasso F; Orlando P; Di Marzo V
Br J Pharmacol; 2012 Jun; 166(4):1444-60. PubMed ID: 22300105
[TBL] [Abstract][Full Text] [Related]
10. Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice.
Cluny NL; Keenan CM; Duncan M; Fox A; Lutz B; Sharkey KA
J Pharmacol Exp Ther; 2010 Sep; 334(3):973-80. PubMed ID: 20571060
[TBL] [Abstract][Full Text] [Related]
11. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats.
Duncan M; Mouihate A; Mackie K; Keenan CM; Buckley NE; Davison JS; Patel KD; Pittman QJ; Sharkey KA
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G78-G87. PubMed ID: 18483180
[TBL] [Abstract][Full Text] [Related]
13. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
[TBL] [Abstract][Full Text] [Related]
14. Novel derivatives of 1,2,3-triazole, cannabinoid-1 receptor ligands modulate gastrointestinal motility in mice.
Szymaszkiewicz A; Zielinska M; Li K; Ramanathan M; Alam S; Hou DR; Fichna J; Storr M
Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):435-444. PubMed ID: 29404698
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.
Capasso R; Borrelli F; Aviello G; Romano B; Scalisi C; Capasso F; Izzo AA
Br J Pharmacol; 2008 Jul; 154(5):1001-8. PubMed ID: 18469842
[TBL] [Abstract][Full Text] [Related]
16. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
Ramesh D; Ross GR; Schlosburg JE; Owens RA; Abdullah RA; Kinsey SG; Long JZ; Nomura DK; Sim-Selley LJ; Cravatt BF; Akbarali HI; Lichtman AH
J Pharmacol Exp Ther; 2011 Oct; 339(1):173-85. PubMed ID: 21719468
[TBL] [Abstract][Full Text] [Related]
17. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
Naidu PS; Booker L; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134
[TBL] [Abstract][Full Text] [Related]
18. AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.
Keenan CM; Storr MA; Thakur GA; Wood JT; Wager-Miller J; Straiker A; Eno MR; Nikas SP; Bashashati M; Hu H; Mackie K; Makriyannis A; Sharkey KA
Br J Pharmacol; 2015 May; 172(9):2406-18. PubMed ID: 25572435
[TBL] [Abstract][Full Text] [Related]
19. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT).
Bashashati M; Fichna J; Piscitelli F; Capasso R; Izzo AA; Sibaev A; Timmermans JP; Cenac N; Vergnolle N; Di Marzo V; Storr M
Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695708
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.
Brown I; Cascio MG; Wahle KW; Smoum R; Mechoulam R; Ross RA; Pertwee RG; Heys SD
Carcinogenesis; 2010 Sep; 31(9):1584-91. PubMed ID: 20660502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
